1. Home
  2. EDSA vs TKLF Comparison

EDSA vs TKLF Comparison

Compare EDSA & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EDSA
  • TKLF
  • Stock Information
  • Founded
  • EDSA 2015
  • TKLF 2006
  • Country
  • EDSA Canada
  • TKLF Japan
  • Employees
  • EDSA N/A
  • TKLF N/A
  • Industry
  • EDSA Biotechnology: Pharmaceutical Preparations
  • TKLF Other Specialty Stores
  • Sector
  • EDSA Health Care
  • TKLF Consumer Discretionary
  • Exchange
  • EDSA Nasdaq
  • TKLF Nasdaq
  • Market Cap
  • EDSA 18.6M
  • TKLF 15.6M
  • IPO Year
  • EDSA N/A
  • TKLF 2022
  • Fundamental
  • Price
  • EDSA $2.66
  • TKLF $3.26
  • Analyst Decision
  • EDSA Strong Buy
  • TKLF
  • Analyst Count
  • EDSA 2
  • TKLF 0
  • Target Price
  • EDSA $13.00
  • TKLF N/A
  • AVG Volume (30 Days)
  • EDSA 140.8K
  • TKLF 179.5K
  • Earning Date
  • EDSA 12-12-2025
  • TKLF 07-10-2025
  • Dividend Yield
  • EDSA N/A
  • TKLF N/A
  • EPS Growth
  • EDSA N/A
  • TKLF N/A
  • EPS
  • EDSA N/A
  • TKLF 1.57
  • Revenue
  • EDSA N/A
  • TKLF $210,119,238.00
  • Revenue This Year
  • EDSA N/A
  • TKLF N/A
  • Revenue Next Year
  • EDSA N/A
  • TKLF N/A
  • P/E Ratio
  • EDSA N/A
  • TKLF $2.20
  • Revenue Growth
  • EDSA N/A
  • TKLF 7.38
  • 52 Week Low
  • EDSA $1.55
  • TKLF $2.20
  • 52 Week High
  • EDSA $4.49
  • TKLF $5.45
  • Technical
  • Relative Strength Index (RSI)
  • EDSA 54.92
  • TKLF 39.44
  • Support Level
  • EDSA $2.42
  • TKLF $2.98
  • Resistance Level
  • EDSA $2.95
  • TKLF $3.62
  • Average True Range (ATR)
  • EDSA 0.21
  • TKLF 0.23
  • MACD
  • EDSA 0.01
  • TKLF -0.04
  • Stochastic Oscillator
  • EDSA 49.86
  • TKLF 35.35

About EDSA Edesa Biotech Inc.

Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores, Online Stores and Services, and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from Hong Kong, followed by Japan, the United States, and other overseas markets.

Share on Social Networks: